CA2391416A1 - Combinaisons oncolytiques destinees au traitement du cancer - Google Patents
Combinaisons oncolytiques destinees au traitement du cancer Download PDFInfo
- Publication number
- CA2391416A1 CA2391416A1 CA002391416A CA2391416A CA2391416A1 CA 2391416 A1 CA2391416 A1 CA 2391416A1 CA 002391416 A CA002391416 A CA 002391416A CA 2391416 A CA2391416 A CA 2391416A CA 2391416 A1 CA2391416 A1 CA 2391416A1
- Authority
- CA
- Canada
- Prior art keywords
- ethyl
- propoxy
- fluorophenyl
- hydroxyphenoxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Selon l'invention, des antagonistes de leucotriène (LTB¿4?) augmentent l'efficacité des agents anti-cancéreux 2',2'-difluoronucléosides.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16478699P | 1999-11-11 | 1999-11-11 | |
US60/164,786 | 1999-11-11 | ||
PCT/US2000/031039 WO2001034137A2 (fr) | 1999-11-11 | 2000-11-09 | Combinaisons oncolytiques destinees au traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2391416A1 true CA2391416A1 (fr) | 2001-05-17 |
Family
ID=22596085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002391416A Abandoned CA2391416A1 (fr) | 1999-11-11 | 2000-11-09 | Combinaisons oncolytiques destinees au traitement du cancer |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1231938A2 (fr) |
JP (1) | JP2003513916A (fr) |
KR (1) | KR20020069512A (fr) |
CN (1) | CN1390139A (fr) |
AR (1) | AR032432A1 (fr) |
AU (1) | AU778829B2 (fr) |
BR (1) | BR0015490A (fr) |
CA (1) | CA2391416A1 (fr) |
CZ (1) | CZ20021551A3 (fr) |
EA (1) | EA200200545A1 (fr) |
HK (1) | HK1050132A1 (fr) |
HU (1) | HUP0204449A3 (fr) |
IL (1) | IL148579A0 (fr) |
MX (1) | MXPA02004733A (fr) |
NO (1) | NO20022245L (fr) |
NZ (1) | NZ517667A (fr) |
PE (1) | PE20010701A1 (fr) |
PL (1) | PL355172A1 (fr) |
SK (1) | SK6492002A3 (fr) |
TR (1) | TR200201245T2 (fr) |
WO (1) | WO2001034137A2 (fr) |
ZA (1) | ZA200202822B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034198A2 (fr) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Combinaisons oncolytiques pour traitement des cancers |
US6797723B1 (en) | 1999-11-11 | 2004-09-28 | Eli Lilly And Company | Heterocycle substituted diphenyl leukotriene antagonists |
WO2001034197A2 (fr) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Combinaisons oncolytiques aux fins du traitement de cancer |
JP2001247459A (ja) | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | 癌の組み合わせ療法 |
WO2001085166A1 (fr) * | 2000-05-09 | 2001-11-15 | Creighton University | Procedes servant a inhiber la proliferation et a induire l'apoptose dans des cellules cancereuses |
EP1311262A4 (fr) | 2000-07-28 | 2005-06-01 | Cancer Rec Tech Ltd | Traitement combine contre le cancer |
GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
EP1745003B1 (fr) | 2004-05-05 | 2010-10-27 | High Point Pharmaceuticals, LLC | Nouveaux composes, leur preparation et leur utilisation |
US8053598B2 (en) | 2004-05-05 | 2011-11-08 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
CN1302782C (zh) * | 2005-01-17 | 2007-03-07 | 北京京卫燕康药物研究所有限公司 | 盐酸吉西他滨溶液型注射剂 |
ATE529404T1 (de) | 2005-06-30 | 2011-11-15 | High Point Pharmaceuticals Llc | Phenoxyessigsäuren als ppar-delta-aktivatoren |
NZ568488A (en) | 2005-12-22 | 2011-07-29 | High Point Pharmaceuticals Llc | Phenoxy acetic acids as PPAR delta activators |
EP1999098A2 (fr) | 2006-03-09 | 2008-12-10 | High Point Pharmaceuticals, LLC | Nouveaux composés, leur préparation et utilisation |
EP2080751A4 (fr) | 2006-10-12 | 2011-06-22 | Inst Med Molecular Design Inc | Dérivé d'acide carboxylique |
US8633245B2 (en) | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
WO2014060381A1 (fr) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Composés hétérocycliques pour la lutte contre les nuisibles |
JP2016503395A (ja) | 2012-10-31 | 2016-02-04 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 病害生物防除剤としての複素環化合物 |
CN103319466B (zh) * | 2013-07-04 | 2016-03-16 | 郑州大学 | 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
-
2000
- 2000-11-09 PL PL00355172A patent/PL355172A1/xx not_active Application Discontinuation
- 2000-11-09 IL IL14857900A patent/IL148579A0/xx unknown
- 2000-11-09 AU AU15990/01A patent/AU778829B2/en not_active Ceased
- 2000-11-09 CZ CZ20021551A patent/CZ20021551A3/cs unknown
- 2000-11-09 CA CA002391416A patent/CA2391416A1/fr not_active Abandoned
- 2000-11-09 EA EA200200545A patent/EA200200545A1/ru unknown
- 2000-11-09 WO PCT/US2000/031039 patent/WO2001034137A2/fr active IP Right Grant
- 2000-11-09 TR TR2002/01245T patent/TR200201245T2/xx unknown
- 2000-11-09 SK SK649-2002A patent/SK6492002A3/sk unknown
- 2000-11-09 EP EP00978535A patent/EP1231938A2/fr not_active Withdrawn
- 2000-11-09 MX MXPA02004733A patent/MXPA02004733A/es not_active Application Discontinuation
- 2000-11-09 NZ NZ517667A patent/NZ517667A/en unknown
- 2000-11-09 KR KR1020027006027A patent/KR20020069512A/ko not_active Application Discontinuation
- 2000-11-09 CN CN00815579A patent/CN1390139A/zh active Pending
- 2000-11-09 JP JP2001536137A patent/JP2003513916A/ja not_active Withdrawn
- 2000-11-09 BR BR0015490-3A patent/BR0015490A/pt not_active IP Right Cessation
- 2000-11-09 HU HU0204449A patent/HUP0204449A3/hu unknown
- 2000-11-10 AR ARP000105955A patent/AR032432A1/es unknown
- 2000-11-10 PE PE2000001206A patent/PE20010701A1/es not_active Application Discontinuation
-
2002
- 2002-04-10 ZA ZA200202822A patent/ZA200202822B/xx unknown
- 2002-05-10 NO NO20022245A patent/NO20022245L/no not_active Application Discontinuation
-
2003
- 2003-01-29 HK HK03100750.7A patent/HK1050132A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0204449A2 (hu) | 2003-04-28 |
PE20010701A1 (es) | 2001-07-07 |
SK6492002A3 (en) | 2003-09-11 |
IL148579A0 (en) | 2002-09-12 |
PL355172A1 (en) | 2004-04-05 |
MXPA02004733A (es) | 2002-08-30 |
AU1599001A (en) | 2001-06-06 |
HK1050132A1 (zh) | 2003-06-13 |
JP2003513916A (ja) | 2003-04-15 |
CN1390139A (zh) | 2003-01-08 |
KR20020069512A (ko) | 2002-09-04 |
ZA200202822B (en) | 2003-09-23 |
WO2001034137A2 (fr) | 2001-05-17 |
EP1231938A2 (fr) | 2002-08-21 |
NO20022245L (no) | 2002-07-09 |
NZ517667A (en) | 2004-05-28 |
BR0015490A (pt) | 2002-07-09 |
WO2001034137A3 (fr) | 2002-02-14 |
NO20022245D0 (no) | 2002-05-10 |
HUP0204449A3 (en) | 2006-02-28 |
TR200201245T2 (tr) | 2004-08-23 |
AR032432A1 (es) | 2003-11-12 |
EA200200545A1 (ru) | 2002-12-26 |
AU778829B2 (en) | 2004-12-23 |
CZ20021551A3 (cs) | 2003-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2391416A1 (fr) | Combinaisons oncolytiques destinees au traitement du cancer | |
JP6364028B2 (ja) | 選択的エストロゲン受容体ディグレーダーとしてのベンゾチオフェン誘導体およびその組成物 | |
KR101396606B1 (ko) | 신규 갑상선 호르몬 β 수용체 작동약 | |
TW446704B (en) | Naphtho[2,3-B]heteroar-4-yl derivatives for treating metabolic disorders related to insulin resistance or hyperglycemia | |
ES2397664T3 (es) | Derivados de glucopiranósilo que contienen tienilo como antidiabéticos | |
JP2003531194A (ja) | プロスタグランジンe阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物 | |
CN106188045A (zh) | 作为wnt信号传导抑制剂的化合物、组合物及其应用 | |
Giles et al. | Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives | |
CA2390789A1 (fr) | Combinaisons oncolytiques pour traitement des cancers | |
JP2003509419A (ja) | カルボン酸類およびアシルスルホンアミド類、そのような化合物を含む組成物、ならびに治療方法 | |
US8822519B2 (en) | Compound with agitation effect on peroxisome proliferator-activated receptor process for its preparation and use thereof | |
WO2005079803A1 (fr) | Composes pour traitement des maladies cardio-vasculaires | |
US20170128434A1 (en) | Novel estrogen receptor ligands | |
WO2001034198A2 (fr) | Combinaisons oncolytiques pour traitement des cancers | |
WO2001034197A2 (fr) | Combinaisons oncolytiques aux fins du traitement de cancer | |
ES2207108T3 (es) | Derivados de acido aril carboxilico y tetrazol con un grupo de carbamoiloxi. | |
JP2007530427A (ja) | 細胞毒性作用を有するコンブレタスタチン誘導体 | |
WO2019031470A1 (fr) | Nouveau composé à base d'amide, et inhibiteur de pin1, agent thérapeutique contre les maladies inflammatoires ainsi qu'agent thérapeutique contre le cancer mettant en œuvre celui-ci | |
US10183908B2 (en) | Compositions for the treatment of kidney and/or liver disease | |
GB2397817A (en) | Coumarin derivative | |
JP7345899B2 (ja) | リン酸塩誘導体およびその用途 | |
CA2391230A1 (fr) | Diphenyles a substitution heterocycle utilises comme antagonistes de leucotriene | |
CN106102747A (zh) | 释放no的硝基氧基‑色烯结合物 | |
CN117658885A (zh) | 苄氧芳基类化合物及其制备方法、药物组合物和用途 | |
CN116848095A (zh) | 氘代化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |